» Articles » PMID: 671607

Studies in Inhibitors of Calcification and Levels of Urine Saturation with Calcium Salts in Recurrent Stone Patients

Overview
Journal J Urol
Publisher Wolters Kluwer
Specialty Urology
Date 1978 Jul 1
PMID 671607
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Studies have been done on patients with recurrent renal calculous disease, measuring in addition to the usual serum and urine constituents the inhibiting capacity of the urine and the activity products of calcium oxalate, octocalcium phosphate and brushite. Studies on the 24-hour urine calcium, phosphorus and uric acid and serum calcium indicate no essential differences between patients with calcium oxalate, mixed or uric acid stones and normal individuals. We were unable to demonstrate a difference in the inhibiting capacity of the urine between normal individuals and patients with calcium oxalate calculi, and levels of saturation of urine with calcium oxalate were identical in the calcium oxalate stone patients and normal individuals. The degree of saturation of urine with calcium phosphate is significantly greater in stone patients.

Citing Articles

Evaluation of urine composition and calcium salt crystallization properties in standardized volume-adjusted 12-h night urine from normal subjects and calcium oxalate stone formers.

Tiselius H Urol Res. 1997; 25(5):365-72.

PMID: 9373919 DOI: 10.1007/BF01294667.


Urinary inhibitors of calcium oxalate crystallization and their potential role in stone formation.

Ryall R World J Urol. 1997; 15(3):155-64.

PMID: 9228722 DOI: 10.1007/BF02201852.


The scientific basis of calcium oxalate urolithiasis. Predilection and precipitation, promotion and proscription.

Ryall R World J Urol. 1993; 11(1):59-65.

PMID: 8490669 DOI: 10.1007/BF00182173.